251 related articles for article (PubMed ID: 29138861)
1. Immunogenic tumor cell death induced by chemotherapy in patients with breast cancer and esophageal squamous cell carcinoma.
Aoto K; Mimura K; Okayama H; Saito M; Chida S; Noda M; Nakajima T; Saito K; Abe N; Ohki S; Ohtake T; Takenoshita S; Kono K
Oncol Rep; 2018 Jan; 39(1):151-159. PubMed ID: 29138861
[TBL] [Abstract][Full Text] [Related]
2. Immunogenic tumor cell death induced by chemoradiotherapy in patients with esophageal squamous cell carcinoma.
Suzuki Y; Mimura K; Yoshimoto Y; Watanabe M; Ohkubo Y; Izawa S; Murata K; Fujii H; Nakano T; Kono K
Cancer Res; 2012 Aug; 72(16):3967-76. PubMed ID: 22700877
[TBL] [Abstract][Full Text] [Related]
3. Immunoregulatory influence of abundant MFG-E8 expression by esophageal cancer treated with chemotherapy.
Kanemura T; Miyata H; Makino T; Tanaka K; Sugimura K; Hamada-Uematsu M; Mizote Y; Uchida H; Miyazaki Y; Takahashi T; Kurokawa Y; Yamasaki M; Wada H; Nakajima K; Takiguchi S; Mori M; Doki Y; Tahara H
Cancer Sci; 2018 Nov; 109(11):3393-3402. PubMed ID: 30156356
[TBL] [Abstract][Full Text] [Related]
4. GR, Sgk1, and NDRG1 in esophageal squamous cell carcinoma: their correlation with therapeutic outcome of neoadjuvant chemotherapy.
Ueki S; Fujishima F; Kumagai T; Ishida H; Okamoto H; Takaya K; Sato C; Taniyma Y; Kamei T; Sasano H
BMC Cancer; 2020 Feb; 20(1):161. PubMed ID: 32106831
[TBL] [Abstract][Full Text] [Related]
5. CDK12/13 inhibition induces immunogenic cell death and enhances anti-PD-1 anticancer activity in breast cancer.
Li Y; Zhang H; Li Q; Zou P; Huang X; Wu C; Tan L
Cancer Lett; 2020 Dec; 495():12-21. PubMed ID: 32941949
[TBL] [Abstract][Full Text] [Related]
6. Radiosensitization of esophageal carcinoma cells by knockdown of HMGB1 expression.
Zhang X; Yang X; Zhu S; Li Q; Zou N
Oncol Rep; 2019 Mar; 41(3):1960-1970. PubMed ID: 30569171
[TBL] [Abstract][Full Text] [Related]
7. BET bromodomain inhibitor JQ1 promotes immunogenic cell death in tongue squamous cell carcinoma.
Wang M; Zhao L; Tong D; Yang L; Zhu H; Li Q; Zhang F
Int Immunopharmacol; 2019 Nov; 76():105921. PubMed ID: 31600692
[TBL] [Abstract][Full Text] [Related]
8. Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.
Shi X; Chen X; Fang B; Ping Y; Qin G; Yue D; Li F; Yang S; Zhang Y
Biomed Pharmacother; 2019 Apr; 112():108632. PubMed ID: 30797153
[TBL] [Abstract][Full Text] [Related]
9. The immunological impact of neoadjuvant chemotherapy on the tumor microenvironment of esophageal squamous cell carcinoma.
Tsuchikawa T; Miyamoto M; Yamamura Y; Shichinohe T; Hirano S; Kondo S
Ann Surg Oncol; 2012 May; 19(5):1713-9. PubMed ID: 21822560
[TBL] [Abstract][Full Text] [Related]
10. Induction of Immunogenic Cell Death of Esophageal Squamous Cell Carcinoma by 5-Fluorouracil and Cisplatin.
Nishimura J; Deguchi S; Tanaka H; Yamakoshi Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Muguruma K; Ohira M
In Vivo; 2021; 35(2):743-752. PubMed ID: 33622867
[TBL] [Abstract][Full Text] [Related]
11. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
12. High mobility group box 1 promotes radioresistance in esophageal squamous cell carcinoma cell lines by modulating autophagy.
Ma H; Zheng S; Zhang X; Gong T; Lv X; Fu S; Zhang S; Yin X; Hao J; Shan C; Huang S
Cell Death Dis; 2019 Feb; 10(2):136. PubMed ID: 30755598
[TBL] [Abstract][Full Text] [Related]
13. Immunogenic cell death after combined treatment with radiation and ATR inhibitors is dually regulated by apoptotic caspases.
Eek Mariampillai A; Hauge S; Kongsrud K; Syljuåsen RG
Front Immunol; 2023; 14():1138920. PubMed ID: 37346039
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant Chemotherapy Increases PD-L1 Expression and CD8
Fukuoka E; Yamashita K; Tanaka T; Sawada R; Sugita Y; Arimoto A; Fujita M; Takiguchi G; Matsuda T; Oshikiri T; Nakamura T; Suzuki S; Kakeji Y
Anticancer Res; 2019 Aug; 39(8):4539-4548. PubMed ID: 31366557
[TBL] [Abstract][Full Text] [Related]
15. Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy.
de Groot AF; Blok EJ; Charehbili A; Engels CC; Smit VTHBM; Dekker-Ensink NG; Putter H; Meershoek-Klein Kranenbarg E; van de Velde CJH; Liefers GJ; Nortier JWR; Kuppen PJK; van der Burg SH; Kroep JR
Breast Cancer Res Treat; 2019 Jun; 175(3):605-615. PubMed ID: 30868392
[TBL] [Abstract][Full Text] [Related]
16. Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.
Okamoto K; Ninomiya I; Ohbatake Y; Hirose A; Tsukada T; Nakanuma S; Sakai S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Oyama K; Inokuchi M; Nakagawara H; Miyashita T; Hidehiro T; Takamura H; Fushida S; Ohta T
Oncol Rep; 2016 Dec; 36(6):3333-3342. PubMed ID: 27748881
[TBL] [Abstract][Full Text] [Related]
17. Peritumoral B cells drive proangiogenic responses in HMGB1-enriched esophageal squamous cell carcinoma.
Kam NW; Wu KC; Dai W; Wang Y; Yan LYC; Shakya R; Khanna R; Qin Y; Law S; Lo AWI; Lee VHF; Guan XY; Kwong DL
Angiogenesis; 2022 May; 25(2):181-203. PubMed ID: 34617194
[TBL] [Abstract][Full Text] [Related]
18. High-mobility group box 1 protein modulated proliferation and radioresistance in esophageal squamous cell carcinoma.
Di X; He G; Chen H; Zhu C; Qin Q; Yan J; Zhang X; Sun X
J Gastroenterol Hepatol; 2019 Apr; 34(4):728-735. PubMed ID: 29968320
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death.
Hodge JW; Garnett CT; Farsaci B; Palena C; Tsang KY; Ferrone S; Gameiro SR
Int J Cancer; 2013 Aug; 133(3):624-36. PubMed ID: 23364915
[TBL] [Abstract][Full Text] [Related]
20. Efficient induction of anti-tumor immune response in esophageal squamous cell carcinoma via dendritic cells expressing MAGE-A3 and CALR antigens.
Liu X; Song N; Liu Y; Liu Y; Li J; Ding J; Tong Z
Cell Immunol; 2015 Jun; 295(2):77-82. PubMed ID: 25863743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]